Skip to main content
. 2018 Oct 31;38(5):BSR20180914. doi: 10.1042/BSR20180914

Figure 2. Isolation of circulating ALDH1+ cells from the serum of NSCLC patients.

Figure 2

(A) CTCs are identified by using the Immunofluorescence assay with CK, DAPI, and CD45. (B) ALDEFLUOR FACS analysis of the CTCs. (C) Circulating ALDH1+ cells were calculated by using FCM in patients and healthy controls. *P<0.05 (D) Kaplan–Meier curves of the cumulative survival rate of the NSCLC patients based on the number of circulating ALDH1+ cells. *P=0.03 (E) Correlation between sTRAIL and circulating ALDH1+ cells in the NSCLC patients.